Titre:
  • An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06)
Auteur:Risi, Emanuela; Biagioni, Chiara; Benelli, Matteo; Migliaccio, Ilenia; McCartney, Amelia; Bonechi, Martina; Guarducci, Cristina; Hilbers, Florentine FS; Di Cosimo, Serena; Huober, J.; Romagnoli, Dario; Boccalini, Giulia; Vitale, Stefania; Sotiriou, Christos; Biganzoli, Laura; Di Leo, A.; Malorni, Luca
Informations sur la publication:Therapeutic advances in medical oncology, 11
Statut de publication:Publié, 2019-01-01
Sujet CREF:Cancérologie
Sciences bio-médicales et agricoles
Médecine pathologie humaine
Mots-clés:gene expression profiling
HER2+ breast cancer
neoadjuvant chemotherapy
predictive biomarker
RB pathway
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1758-8340
info:doi/10.1177/1758835919891608
info:pii/10.1177_1758835919891608
info:scp/85076627598
info:pmid/31853266
PMC6906346